Go Pro
OTCMKTS:MAQAF

Atlas Arteria (MAQAF) Stock Price, News & Analysis

Atlas Arteria logo
$3.55 0.00 (0.00%)
As of 07/10/2026

About Atlas Arteria Stock (OTCMKTS:MAQAF)

Advanced

Key Stats

Today's Range
$3.55
$3.55
50-Day Range
$3.30
$3.64
52-Week Range
$2.69
$3.70
Volume
N/A
Average Volume
1,344 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
2.34%
Price Target
$4.75
Consensus Rating
Sell

Company Overview

Atlas Arteria Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
16th Percentile Overall Score

MAQAF MarketRank™: 

Atlas Arteria scored higher than 16% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Atlas Arteria has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

  • Upside Potential

    Atlas Arteria has a consensus price target of $4.75, representing about 33.9% upside from its current price of $3.55.

  • Amount of Analyst Coverage

    Atlas Arteria has only been the subject of 1 research reports in the past 90 days.

  • Read more about Atlas Arteria's stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Atlas Arteria is -34.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Atlas Arteria is -34.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Read more about Atlas Arteria's valuation and earnings.
  • Percentage of Shares Shorted

  • Short Interest Ratio / Days to Cover

    Atlas Arteria has a short interest ratio ("days to cover") of 999.99, which indicates bearish sentiment.
  • Change versus previous month

    Short interest in Atlas Arteria has recently increased by 264.35%, indicating that investor sentiment is decreasing significantly.
  • Dividend Leadership

    Atlas Arteria is a leading dividend payer. It pays a dividend yield of 5.02%, putting its dividend yield in the top 25% of dividend-paying stocks.

  • Dividend Growth

    Atlas Arteria does not have a long track record of dividend growth.

  • Read more about Atlas Arteria's dividend.
  • News Sentiment

    Atlas Arteria has a news sentiment score of -1.00. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.60 average news sentiment score of Industrials companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Atlas Arteria this week, compared to 0 articles on an average week.
Receive MAQAF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atlas Arteria and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

MAQAF Stock News Headlines

The top stock. Ticker. Revealed for everyone to see.
Project Janus is a little-known initiative with ties to the White House, U.S. Army, and Department of Energy - and it targets the entire $3.7 trillion global energy sector. Chief Investment Strategist Adam O'Dell believes its new fuel source, set to go online before December 18, 2026, could eliminate AI power bottlenecks and grid failures. He's releasing the name and ticker of his top stock pick at no charge.tc pixel
Citi Sticks to Their Hold Rating for Atlas Arteria (MAQAF)
Citi Remains a Hold on Atlas Arteria (MAQAF)
See More Headlines

MAQAF Stock Analysis - Frequently Asked Questions

Atlas Arteria's stock was trading at $2.84 at the beginning of the year. Since then, MAQAF stock has increased by 24.9% and is now trading at $3.5475.

Shares of MAQAF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Today
7/12/2026
Next Earnings (Estimated)
8/27/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Infrastructure Operations
Sub-Industry
N/A
Current Symbol
OTCMKTS:MAQAF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Price Target and Rating

High Price Target
$4.75
Low Price Target
$4.75
Potential Upside/Downside
+33.9%
Consensus Rating
Sell
Rating Score (0-4)
1.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report

This page (OTCMKTS:MAQAF) was last updated on 7/12/2026 by MarketBeat.com Staff.
From Our Partners